These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 31375851)

  • 1. [New technologies in diabetes treatment].
    Serfling G; Kalscheuer H; Schmid SM; Lehnert H
    Internist (Berl); 2019 Sep; 60(9):912-916. PubMed ID: 31375851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous Glucose Monitoring, Future Products, and Update on Worldwide Artificial Pancreas Projects.
    Kropff J; DeVries JH
    Diabetes Technol Ther; 2016 Feb; 18 Suppl 2(Suppl 2):S253-63. PubMed ID: 26784131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perioperative Considerations for Evolving Artificial Pancreas Devices.
    Long MT; Coursin DB; Rice MJ
    Anesth Analg; 2019 May; 128(5):902-906. PubMed ID: 30198923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Artificial Pancreas and Type 1 Diabetes.
    Nwokolo M; Hovorka R
    J Clin Endocrinol Metab; 2023 Jun; 108(7):1614-1623. PubMed ID: 36734145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes.
    Rodbard D
    Diabetes Technol Ther; 2017 Jun; 19(S3):S25-S37. PubMed ID: 28585879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Artificial pancreas: where are we in 2020 ?].
    Radermecker RP
    Rev Med Suisse; 2020 Aug; 16(703):1494-1497. PubMed ID: 32852170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiniMed 670G hybrid closed loop artificial pancreas system for the treatment of type 1 diabetes mellitus: overview of its safety and efficacy.
    Saunders A; Messer LH; Forlenza GP
    Expert Rev Med Devices; 2019 Oct; 16(10):845-853. PubMed ID: 31540557
    [No Abstract]   [Full Text] [Related]  

  • 9. [Closed-loop systems - Update 2020].
    Melmer A; Tripyla A; Herzig D; Laimer M; Stettler C; Bally L
    Ther Umsch; 2020 Sep; 77(7):312-318. PubMed ID: 32996429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of Technology on Current Diabetes Management.
    Garvey K; Wolfsdorf JI
    Pediatr Clin North Am; 2015 Aug; 62(4):873-88. PubMed ID: 26210622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes.
    Del Favero S; Place J; Kropff J; Messori M; Keith-Hynes P; Visentin R; Monaro M; Galasso S; Boscari F; Toffanin C; Di Palma F; Lanzola G; Scarpellini S; Farret A; Kovatchev B; Avogaro A; Bruttomesso D; Magni L; DeVries JH; Cobelli C; Renard E;
    Diabetes Obes Metab; 2015 May; 17(5):468-76. PubMed ID: 25600304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modern clinical management helps reducing the impact of type 1 diabetes in children.
    Scaramuzza AE; Zuccotti GV
    Pharmacol Res; 2015 Aug; 98():16-21. PubMed ID: 25779986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An artificial pancreas for automated blood glucose control in patients with Type 1 diabetes.
    Schmidt S; Boiroux D; Ranjan A; Jørgensen JB; Madsen H; Nørgaard K
    Ther Deliv; 2015; 6(5):609-19. PubMed ID: 26001176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artificial Pancreas: Current Progress and Future Outlook in the Treatment of Type 1 Diabetes.
    Ramli R; Reddy M; Oliver N
    Drugs; 2019 Jul; 79(10):1089-1101. PubMed ID: 31190305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [From insulin pump and continuous glucose monitoring to the artificial pancreas].
    Apablaza P; Soto N; Codner E
    Rev Med Chil; 2017 May; 145(5):630-640. PubMed ID: 28898340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automated hybrid closed-loop control with a proportional-integral-derivative based system in adolescents and adults with type 1 diabetes: individualizing settings for optimal performance.
    Ly TT; Weinzimer SA; Maahs DM; Sherr JL; Roy A; Grosman B; Cantwell M; Kurtz N; Carria L; Messer L; von Eyben R; Buckingham BA
    Pediatr Diabetes; 2017 Aug; 18(5):348-355. PubMed ID: 27191182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Technological innovations in the treatment of type 1 diabetes in pediatrics].
    Tubiana-Rufi N
    Soins Pediatr Pueric; 2016; (288):38-40. PubMed ID: 26776695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity of the Predictive Hypoglycemia Minimizer System to the Algorithm Aggressiveness Factor.
    Finan DA; Dassau E; Breton MD; Patek SD; McCann TW; Kovatchev BP; Doyle FJ; Levy BL; Venugopalan R
    J Diabetes Sci Technol; 2015 Jun; 10(1):104-10. PubMed ID: 26134834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Closed-Loop Control of Postprandial Glycemia Using an Insulin-on-Board Limitation Through Continuous Action on Glucose Target.
    Rossetti P; Quirós C; Moscardó V; Comas A; Giménez M; Ampudia-Blasco FJ; León F; Montaser E; Conget I; Bondia J; Vehí J
    Diabetes Technol Ther; 2017 Jun; 19(6):355-362. PubMed ID: 28459603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artificial pancreas: an emerging approach to treat Type 1 diabetes.
    Kumareswaran K; Evans ML; Hovorka R
    Expert Rev Med Devices; 2009 Jul; 6(4):401-10. PubMed ID: 19572795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.